文献速递急性肾损伤

超声评估液体耐受性指导急性肾损伤管理的试点随机对照试验

A Pilot Randomized Controlled Trial of Ultrasound Evaluation of Fluid Tolerance for Acute Kidney Injury: USE-the-FORCE-for-AKI Trial.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-04-21

本研究为单中心、开放标签、试点随机对照试验,纳入非危重急性肾损伤患者80例,比较基于床旁超声(POCUS)的液体耐受性评估策略与常规护理。

要点

  • POCUS报告使50%患者管理改变,临床医生认为有用(中位4.5/5)。
  • 干预组早期利尿剂使用增加,但未导致肾功能恶化或不良结局。

核心结论

  • 试点试验表明,在AKI患者中开展POCUS液体耐受性评估的随机对照试验是可行的。
  • POCUS对临床管理有影响且被临床医生认为有用,支持未来开展更大规模研究。

研究设计与样本

  • 单中心、开放标签、试点随机对照试验,纳入非危重急性肾损伤患者80例,随机分为POCUS组和常规护理组各40例,其中1例在试验程序开始前退出知情同意。
  • 干预措施为向肾内科团队传递基于肺B线和静脉过量超声评分的POCUS液体耐受性报告,对照组为无POCUS的常规护理。
  • 主要结局为可行性,定义为方案依从性。

主要发现

  • 方案依从性在所有患者中达成。
  • 干预组中50%的初始超声报告导致临床行为改变,所提供信息被临床医生认为有用(中位4.5/5,四分位距4.0-5.0)。
  • 干预组随机化后第一天利尿剂使用率更高(40% vs 15%,P=0.01)。
  • 5天累积液体平衡或利尿剂使用、AKI进展至更高分期、死亡和升级治疗的复合结局均无差异。

临床怎么用

  • POCUS评估液体耐受性可影响AKI患者的临床管理,增加早期利尿剂使用而不损害肾功能。
  • 临床医生对POCUS报告感知有用性高,可考虑在AKI液体管理中整合POCUS评估。

局限性

  • 本研究为试点试验,样本量小,主要目的是评估可行性而非临床疗效。
  • 单中心、开放标签设计可能引入偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Point-of-care ultrasound could provide important information to guide fluid administration in AKI. This study demonstrates the feasibility assessing fluid tolerance through lung and venous ultrasound and implementing it in a trial. Point-of-care ultrasound influenced management in half of patients and lead to higher rate of early diuretic use without negatively affecting kidney function. BACKGROUND: Indiscriminate fluid administration in AKI can be harmful, and point-of-care ultrasound (POCUS) could be used to assess for fluid tolerance. The objective of pilot study was to determine the feasibility of a randomized trial comparing a fluid management strategy, including POCUS, with usual care. METHODS: This is a single-center, open-label, pilot randomized controlled trial that recruited noncritically ill patients with AKI for whom fluid administration had begun or was considered. The intervention consisted in the transmission to the nephrology team of a POCUS report on fluid tolerance (assessment of pulmonary B-lines and systemic venous congestion with the venous excess ultrasound score). The control was usual care without POCUS. The primary outcome was feasibility, defined as protocol adherence. RESULTS: Eighty patients underwent randomization, 40 were randomized in the POCUS group and 40 in the usual care group, but one withdrew consent before initiating trial procedures. Protocol adherence was achieved in all patients. In the intervention arm, 50% of initial ultrasound reports led to a change in clinical conduct, and the provided information was perceived as useful by clinicians (median 4.5/5 [interquartile range, 4.0-5.0]). The intervention led to a higher use of diuretics during the first day after randomization (40% versus 15%, P = 0.01), but did not result in difference in cumulative fluid balance or diuretic use at 5 days, progression to higher stages of AKI, or composite outcome of death and escalation of care. CONCLUSIONS: This pilot trial demonstrate the feasibility of a randomized trial investigating the clinical effect of providing a POCUS fluid tolerance evaluation in AKI. Its effect on clinical management and perceived usefulness support the rationale for future, larger-scale studies.Clinical Trial registry name and registration number: NCT06411080 .

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Gouin M, Huard K, Shen A, et al. A Pilot Randomized Controlled Trial of Ultrasound Evaluation of Fluid Tolerance for Acute Kidney Injury: USE-the-FORCE-for-AKI Trial. Clin J Am Soc Nephrol. 2026. PMID: 42012891. doi:10.2215/CJN.0000001059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。